Do probiotic interventions improve female unexplained infertility? A critical commentary
Reproductive BioMedicine Online · 2024-04 · 48 (4) · 103734
DOI: 10.1016/j.rbmo.2023.103734 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproductive BioMedicine Online, 2024-04. Verfasst von Alessia Favaron und 5 weiteren Autor:innen. Beteiligte Einrichtung: UCL School of Pharmacy, University College London, London, UK. Hauptthemen laut MEDLINE: Infertility, Female, Endometriosis, Probiotics. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie, Horizon 2020, H2020 Marie Skłodowska-Curie Actions.
Abstract (Originalsprache)
Disruption of women's gut and cervicovaginal microbiota has been associated with multiple gynaecological diseases such as endometriosis, polycystic ovary syndrome, non-cyclic pelvic pain and infertility. Female infertility affects 12.6% of women worldwide; its aetiology is complex and multifactorial and can be underpinned by uterine pathologies, systemic diseases and age. In addition, a new perspective has emerged on the role of the gut and vaginal microbiomes in reproductive health. Research shows that the administration of precisely selected probiotics, often in combination with prior antibiotic treatment, may facilitate the restoration of symbiotic microbiota to increase successful conception and assisted reproductive technology outcomes. However, clarity on this issue from fuller research is currently hampered by a lack of consistency and harmonization in clinical studies: various lactobacilli and bifidobacteria species have been delivered through both the oral and vaginal routes, in different dosages, for different treatment durations. This commentary explores the intricate relationship between the microbiota in the cervicovaginal area and gut of women, exploring their potential contribution to infertility. It highlights ongoing research on the use of probiotic formulations in improving pregnancy outcomes, critically examining the divergent findings in these studies, which complicate a conclusive assessment of the efficacy of these interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- UCL School of Pharmacy, University College London, London, UK.
- Department of Gynaecology and Obstetrics, School of Medicine, Koc University, Istanbul, Turkey.
Förderung
- European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie
- Horizon 2020
- H2020 Marie Skłodowska-Curie Actions
Zitieren
APA
Favaron, A., Turkgeldi, E., Elbadawi, M., Gaisford, S., Basit, A. W., & Orlu, M. (2024). Do probiotic interventions improve female unexplained infertility? A critical commentary. Reproductive BioMedicine Online, 48(4), 103734. https://doi.org/10.1016/j.rbmo.2023.103734
Vancouver
Favaron A, Turkgeldi E, Elbadawi M, Gaisford S, Basit AW, Orlu M. Do probiotic interventions improve female unexplained infertility? A critical commentary. Reproductive BioMedicine Online. 2024;48(4):103734. doi:10.1016/j.rbmo.2023.103734
BibTeX
@article{Favaron2024,
author = {Favaron, Alessia and Turkgeldi, Engin and Elbadawi, Moe and Gaisford, Simon and Basit, Abdul W and Orlu, Mine},
title = {Do probiotic interventions improve female unexplained infertility? A critical commentary},
journal = {Reproductive BioMedicine Online},
year = {2024},
volume = {48},
number = {4},
pages = {103734},
doi = {10.1016/j.rbmo.2023.103734}
}
EUVIMED